Tianjin Development Renews Service Contracts With Associate

MT NewswiresNov 15 21:02

Tianjin dev: Tianjin Lisheng Pharmaceutical's net income attributable to the parent company in the first three quarters decreased by 50.6% to 0.169 billion yuan.

Tianjin dev (00882) announced that tianjin lisheng pharmaceutical, an indirectly wholly-owned subsidiary, achieved total operating income of 1.024 billion yuan (RMB, the same below) for the nine months ended September 30, 2024, a year-on-year increase of 12.3%; net income attributable to the owners of the parent company was 0.169 billion yuan, a year-on-year decrease of 50.6%; and basic earnings per share was 0.66 yuan.

Sina Hong Kong stocksOct 30 07:27

Tianjin DEV (00882): Tianjin Lisheng Pharmaceutical's net income attributable to mother for the first three quarters was 0.169 billion yuan.

tianjin dev (00882) announced that its indirect non-wholly-owned subsidiary tianjin lisheng pharmaceutical as at 3 September 2024...

Zhitong FinanceOct 30 06:12

TIANJIN DEV: Unaudited Financial Results for the nine months ended 30 September 2024 of Tianjin Lisheng Pharmaceutical Co., Ltd.

HKEXOct 30 06:02 · Announcements

Tianjin Lisheng Invests 210 Million Yuan in China Bohai Bank's Structured Deposit

MT NewswiresSep 27 17:38

tianjin dev (00882.HK) subsidiary subscribed 0.21 billion yuan for another structured deposit.

Grill Lockmate September 26th Tianjin Dev (00882.HK) announced that due to the expiration of the previous structured deposits, on September 26, 2024, the company's indirectly controlled non-wholly-owned subsidiary Tianjin Lisheng Pharmaceutical and CBHB signed a third CBHB wealth management agreement, subscribing to another structured deposit with a principal amount of RMB 0.21 billion.

Gelonghui FinanceSep 26 20:14